Skip to main content
FutureChem Co., Ltd. logo

FutureChem Co., Ltd. — Investor Relations & Filings

Ticker · 220100 ISIN · KR7220100002 KO Manufacturing
Open in API
Filings indexed 312 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 220100

About FutureChem Co., Ltd.

https://www.futurechem.co.kr/?language=…

FutureChem Co., Ltd. is a company specializing in the development and production of radiopharmaceuticals for diagnostic and therapeutic applications. The company's operations cover the manufacturing of radiopharmaceutical precursors, chemical compounds, synthesis reagents, and automated synthesis modules. Its product pipeline focuses on agents for the diagnosis and treatment of various cancers and neurological disorders, including Parkinson's disease. FutureChem supports the broader radiopharmaceutical field by providing both finished products and the essential chemical building blocks and equipment required for their synthesis. The company actively establishes global partnerships for clinical supply and commercial licensing of its technologies.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 94% confidence The document is titled “분기보고서 (제 26기) 2026년 01월 01일 – 2026년 03월 31일” (Quarterly Report for Q1 2026) and contains detailed company overview, tables of subsidiaries, share capital changes, and other substantive financial and operational data. It is clearly the actual interim quarterly report rather than an announcement. Therefore, it should be classified as an Interim/Quarterly Report. Q1 2026
2026-05-14 Korean
투자판단관련주요경영사항 (프로스타뷰주사액([18F]플로라스타민) 식품의약품안전처 신약 허가)
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement regarding the approval of a new drug by the Korean Ministry of Food and Drug Safety (MFDS). It details the drug name, approval date, intended use, and future plans related to insurance and clinical studies. The document is short (1876 characters) and serves as an official notification of a significant corporate event related to investment decisions. It does not contain financial statements, audit information, or detailed financial analysis. It is not a report like an Annual Report or Interim Report, nor is it a transcript or presentation. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about a material event affecting the company, without fitting into more specific categories.
2026-05-04 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is the formal results of the Annual General Meeting held on 2026-03-26, including vote counts, approval status of each resolution, and detailed voting percentages. This matches the definition of "Declaration of Voting Results & Voting Rights Announcements" for shareholder meeting outcomes. Therefore, the appropriate filing code is DVA.
2026-03-26 Korean
기타경영사항(자율공시) (자기사채(제3회 전환사채) 소각 결정)
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a company's decision to cancel its own convertible bonds (자기사채 소각 결정). This relates to capital structure changes and debt management. Since it involves the cancellation of debt instruments (convertible bonds) to enhance shareholder value, it falls under capital/financing updates. It does not fit the specific criteria for share buybacks (POS) or share issues (SHA), making 'CAP' the most accurate classification for this financing-related corporate action.
2026-03-18 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2025, submitted by FutureChem Co., Ltd. to the Financial Services Commission and the Korea Exchange. It contains comprehensive information including company overview, history, capital changes, and shareholding structure. As it is a full-year comprehensive financial and operational report, it is classified as an Annual Report (10-K). FY 2025
2026-03-18 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and is a formal filing submitted to the Financial Services Commission/Korea Exchange. It contains detailed information regarding the solicitation of proxies for the upcoming Annual General Meeting (AGM), including voting procedures, electronic voting details, and the agenda items. While it contains financial statements, these are included as part of the proxy materials to inform shareholders for the meeting, which is standard for a Proxy Solicitation & Information Statement (PSI).
2026-03-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.